Sorry, you need to enable JavaScript to visit this website.

What is YONDELIS® (trabectedin)?

SUPPORTING YOUR JOURNEY FORWARD

 

Janssen — Your Partner for Cost Support

At Janssen, we don’t want cost to get in the way of treatment you need. We can help you explore options that may help to lower your out-of-pocket medication cost for YONDELIS®. Explore savings options at JanssenCarePath.com/YONDELIS (link is external).

YONDELIS® treatment

YONDELIS® is given as an intravenous (IV) infusion into a vein over 24 hours every 3 weeks. If you experience side effects, your doctor may recommend a decrease in dose and/or delay your dose to prevent worsening or recurrence of side effects with YONDELIS®. For more information, please see full Prescribing Information.

 

Watch a video to experience a typical infusion with YONDELIS®.

 

What is advanced soft tissue sarcoma?

Advanced soft tissue sarcoma is a type of cancer that develops from the soft tissues of the body, such as fat, muscle, nerves, fibrous tissues, blood vessels, or deep skin tissues.

 

Read more about soft tissue sarcoma.

 

Talking to your doctor

There are important topics you should discuss with your doctor before you start treatment with YONDELIS®.

 

Explore topics to discuss with your doctor.

 

Safety considerations

There are important considerations and things to be aware of both before and during treatment with YONDELIS®.

 

Janssen CarePath

Janssen CarePath offers access, affordability, and treatment support, including assistance with insurance benefits investigations and other information about accessing your treatment.

 

Patient support

Access downloadable resources that you may find helpful during your treatment with YONDELIS®.